Westlake Chemical Partners Lp Form 4 insider transactions

Randy Woelfel, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.

G Stephen Finley, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.

Lisa A. Friel, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.

Lisa A. Friel, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.

Randy Woelfel, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.

G Stephen Finley, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.

Westlake Chemical Partners' President and CEO, Jean-Marc Gilson, acquired 95.29 common units at $21.25 per unit under a pre-arranged plan, effective August 27, 2025.

Westlake Chemical Partners' President and CEO, Jean-Marc Gilson, has significantly increased his direct beneficial ownership of common units through multiple purchases.

Westlake Chemical Partners LP's President and CEO, Jean-Marc Gilson, amended a Form 4 to report the purchase of an additional 320 common units.

Westlake Chemical Partners LP Director Randy Woelfel reported the acquisition and disposition of common units and phantom units.

A Westlake Chemical Partners LP director reported pre-planned future acquisitions of phantom units and subsequent exercise and partial sale of common units.

Westlake Chemical Partners LP Director G. Stephen Finley converted 4,882 phantom units into common units, increasing his direct beneficial ownership.

James Chao, Senior Chairman and Director of Westlake Chemical Partners LP, has sold all 3,700 of his directly held common units for approximately $81,770.

James Chao, Senior Chairman of Westlake Chemical Partners LP, has sold a total of 10,208 common units in two transactions for approximately $225,000, significantly reducing his direct beneficial ownership.

Jean-Marc Gilson, President and CEO of Westlake Chemical Partners LP, purchased 1,000 common units at $22.83 per unit on August 29, 2024.

Jean-Marc Gilson, President and CEO of Westlake Chemical Partners LP, recently purchased additional common units of the company, increasing his beneficial ownership.

Westlake Chemical Partners LP CEO Jean-Marc Gilson reports purchasing common units of the company's stock in recent transactions.

Andrew Kenner, SVP at Westlake Chemical Partners LP, reports the acquisition and disposition of common units on August 12, 2024.

Director Stephen Finley reports a transaction involving phantom units convertible to common units of Westlake Chemical Partners LP.

Director Randy Woelfel reports a transaction involving Westlake Chemical Partners LP common units, including the conversion of phantom units and disposal of common units.

Lisa A. Friel, a director of Westlake Chemical Partners LP, reported the disposition of common units and phantom units on August 9, 2024.

Andrew Kenner, SVP at Westlake Chemical Partners LP, recently acquired 12,000 common units at an average price of $22.989, increasing his total holdings to 182,308 units.

Director G. Stephen Finley acquired 4,882 phantom units of Westlake Chemical Partners LP on August 7, 2024, convertible to common units.

Lisa A. Friel, a director of Westlake Chemical Partners GP LLC, acquired 4,882 phantom units of Westlake Chemical Partners LP on August 7, 2024.

Director Randy Woelfel acquired 4,882 phantom units of Westlake Chemical Partners LP on August 7, 2024, convertible to common units.

Andrew Kenner, SVP at Westlake Chemical Partners LP, purchased 2,291 common units at $22.23 per unit on May 30, 2024, increasing his total holdings to 170,308 units.

Andrew Kenner, SVP at Westlake Chemical Partners LP, acquired 7,178 common units at an average price of $22.073, increasing his total holdings to 168,017 units.

Director Lisa A. Friel reports a transaction involving Westlake Chemical Partners LP common units, including the acquisition of 4,884 units through phantom units and the disposition of 2,442 units at $22.4.

Andrew Kenner, SVP at Westlake Chemical Partners LP, purchased 10,000 common units of the company at $22.10 per unit on May 8, 2024, increasing his total holdings to 160,839 units.

Andrew Kenner, SVP at Westlake Chemical Partners LP, reports purchasing 5,000 common units at an average price of $22.23, increasing his total holdings to 150,839 units.